Linde Healthcare Continues to Support Innovation in Advanced Respiratory Care
Linde Healthcare, a global business of The Linde Group, has announced the new beneficiaries of its REALfund initiative, a programme supporting ideas and projects with the potential to improve patient outcomes and health economics across the wide field of respiratory medicine.
Selected from many high quality applications from leading clinics and research organisations around the world, three grantees of the REALfund will receive funds to support their innovative research:
- PD Johannes Bickenbach MD and Professor Michael Dreher MD, University Hospital Aachen, Germany, will investigate if exacerbations of invasively mechanically ventilated COPD patients can be predicted by an algorithm based on software analysis of data which will be read out from the ventilator.
- Thomas Bitter MD, Heart and Diabetes Centre Bad Oeynhausen, Germany, will study if high flow oxygen therapy could serve as a new therapeutic approach to treat patients suffering from Cheyne-Stokes respiration associated with Chronic Heart Failure.
- Professor Christopher H. Fanta MD, Brigham and Women’s hospital, Harvard Medical School, Boston, USA, plans to develop a smartphone app which is able to alert COPD patients about deterioration in their breathing and to provide recommendations for patient-initiated first actions to prevent serious exacerbations of their conditions.
Dr Christian Wojczewski, Head of Linde Healthcare states: "Linde Healthcare continues to be committed to co-operating with researchers from around the world to support research and innovative developments in the area of respiratory medicine. The newly awarded REALfund grants fit very well into Linde Healthcare's footprint as global healthcare organisation specialising along an integrated respiratory care path. The work of these researchers, when realised, will help healthcare professionals, support healthcare systems and further improve the quality of care and life for patients."
Grantees of the REALfund are selected with the help of medical and scientific experts and will be supported in their continued research. Dr Konstantin Fiedler, Head of Innovation at Linde Healthcare states: "The aim of Linde Healthcare’s REALfund initiative is to seek and reward ideas that have real potential to be developed into better respiratory care solutions for patients. We are proud of having received many high-quality applications from different regions around the world. We commend all applicants to the fund for their commitment to innovation and idea development in this area of healthcare. The grantees saw the potential in their projects and we at Linde Healthcare are delighted to recognise and reward the ideas that will truly benefit patients."
For further information about the REALfund, please visit:
About Linde Healthcare
Linde Healthcare is a global leader specialising along an integrated respiratory care path. It combines pharmaceutical gases, medical devices, services and clinical care into solutions with the patient in mind. Its products and services make a difference in the lives of its patients and to its healthcare partners in the care continuum from hospital to home. A global business unit of The Linde Group, it is present in over 60 countries and generated revenues of EUR 3.059 bn in 2014 and employs 16,643 employees.
About The Linde Group
In the 2014 financial year, The Linde Group generated revenue of EUR 17.047 bn, making it the largest gases and engineering company in the world with approximately 65,500 employees working in more than 100 countries worldwide. The strategy of The Linde Group is geared towards long-term, profitable growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment - in every one of its business areas, regions and locations across the globe. The company is committed to technologies and products that unite the goals of customer value and sustainable development.
Most Popular Now
Medelinked is now integrated with Microsoft Health and Band. The integration ensures that wellness summary data from Microsoft Health app and Band wearable is available i...Read more
Following a successful pilot programme to deliver more integrated care to heart failure patients, Torbay and South Devon NHS Foundation Trust is rolling out the InterSyst...Read more
During the 2014 FIFA World Cup opening ceremony, a young Brazilian man, paralyzed from the chest down, delivered the opening kickoff. He used a brain-machine interface, a...Read more
Nervecentre Software has launched a mobile clinical photography solution for nurses and doctors in hospitals. Fully integrated directly into the patient record, the mobil...Read more
The term 'in silico clinical trials' refers to: "The use of individualised computer simulation in the development or regulatory evaluation of a medicinal product, medica...Read more
A commonly used device found in living rooms around the world could be a cheap and effective means of evaluating the walking difficulties of multiple sclerosis (MS) patie...Read more
INSIGHTEC, the global leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced the signing of a strategic agreement with the global leader in Magnetic Resonance...Read more
The combination of augmented reality technology, geocaching, and other novel techniques to create innovative active video games (AVGs) has potential personal and public h...Read more
Agfa HealthCare, a leader and innovator in the medical imaging and healthcare IT space, today announced that the U.S. government has awarded the company its DIN-PACS IV (...Read more